Navigation Links
Ebola Treatment Shows Promise

Researchers publishing in the most recent issue of The Lancet believe they’re on the track to a possible treatment for the deadly Ebola virus.//

In a study conducted in rhesus monkeys, researchers found injections of a factor known to inhibit blood coagulation called rNAPc2 led to increased survival rates.

The Ebola virus kills its victims by causing severe hemorrhagic fever. This leads to excessive coagulation of the blood and, ultimately, organ failure. In outbreaks in Zaire, about 80 percent of people who contracted the virus died. The death rate in monkey models of the disease has been nearly 100 percent. These researchers wondered if the disease could be stopped by using rNAPc2 to inhibit the blood coagulation pathway.

Researchers from the United States Army Medical Research Institute of Infectious Diseases tested the treatment in nine monkeys who were intentionally infected with the virus. Three additional monkeys were infected with the virus but received no treatment and served as controls. Results show the treatment prolonged survival time. What’s more, 33 percent of the treated monkeys actually survived the disease and regained their health. Just one of the monkeys in the control group survived until the end of the study, and that monkey subsequently died.

The authors write, “Our results have great clinical implications, since our treatment approach of Ebola hemorrhagic fever targets the disease process rather than replication of the infectious agent.” Noting rNAPc2 has a good safety profile in humans, they believe it might also have a role to play in other viral hemorrhagic fevers. “The clinical efficacy of this treatment modality now needs to be proven,” they conclude.

'"/>




Page: 1

Related medicine news :

1. Ebola Virus - Outbreak Claims More Lives In Uganda.
2. Experimental treatment for Ebola Virus Shows promising results in mice
3. Ebola-like virus is on the way to cause epidemic in Angola
4. Fruit Bats Act As Carriers of Ebola Virus
5. Antisense gene specific therapy for Ebola virus
6. Ebola-Outbreak Kills 5000 Gorillas
7. Research on Vaccine Against Ebola Virus
8. Advances in Treatment of Cataracts
9. Recommendations for Treatment of Blood Pressue
10. Treatment for Menieres disease
11. Treatment for pre-menstrual syndrome is ineffective

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ebola Treatment Shows Promise

(Date:11/22/2009)... HealthSmart, an innovative healthcare benefit...ccessfully completed a recapitalization with Silve...r lenders. Silver Point Capital, L.P. is a privat... This recapitalization allows the Company to cont...y. , , (PRWEB) November ...
(Date:11/21/2009)...N, Nov. 21 Tonight, in ...to Senator Reid,s version of the government takeov... items included in this bill; like the public opti...nment funding for elective abortion, which is the ...ly the bill provides subsidies for private plans t...
(Date:11/21/2009)...ON, Nov. 21 A regional ...ocerciasis (river blindness) in the Americas has s... in recent years, as evidenced by a 31% decrease i...ministration in six endemic countries. Results we...e American Society of Tropical Medicine and Hygien...
(Date:11/21/2009)... Innovative medical apparel company launches m... San Clemente, Calif. (PRWEB) Nov...ough medical apparel, today announced the launch o...ica 2009, a leading international trade fair for t...edelita inaugurates its men,s collection with thre...
(Date:11/21/2009)... Linwood Group ask whether there is a secret t... , London, UK (PRWEB) Nove... to one in three of the adult UK population drinki...lcohol-related liver disease*, it is hardly a surp...itation programmes and residential centres for hel...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
...y, ALLEGAN, Mich., May 21 Perrigo Company,(Nasda...ed into a,collaborative agreement with Cobrek Phar...maceuticals Inc., a privately owned company that s... foam, a $34,million branded pharmaceutical produc...
.... (NYSE: CNO ) at the company,s annual meeting to...expiring at next year,s annual meeting;, -- A... incorporation to eliminate the plurality voti...LP as the company,s independent registered pub...
...have identified a biological explanation for the l...allergy and asthma in childhood. They will present...2008 International Conference in Toronto on Tuesda...d cord blood levels of IL-13, a Th2 type cytokine,...
...d: CRDT), a leading healthcare staffing company, h...arch 31, 2008., Revenue in the quarter was $10,57...revenue of $9,806,540 and an increase of 31% over ...urth quarter of 2007 and $1,712,150 in the first q...
... in very young children may cause some of the adve...er children and adults with the condition, accordi...r findings at the American Thoracic Societys 2008 ...st and sleep specialist who led the study at Ben-G...
...turer,of laser and light-based skin sculpting and ...he introduction of an additional fractional,device...s two new features,-- significantly higher speed, ...aster than competitive instruments, ProFractional-...
Other Medicine News:Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 2Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 3Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 4Health News:Possible biological explanation for C-Section-linked allergies and asthma found 2Health News:Crdentia Announces 2008 First Quarter Results 2Health News:Crdentia Announces 2008 First Quarter Results 3Health News:Crdentia Announces 2008 First Quarter Results 4Health News:Crdentia Announces 2008 First Quarter Results 5Health News:Crdentia Announces 2008 First Quarter Results 6Health News:Crdentia Announces 2008 First Quarter Results 7Health News:Sciton Introduces ProFractional-XC(TM), High-Speed, Dual-Mode Fractional Laser 2
(Date:11/20/2009)..., , NEW YORK, Nov. 20 R...ch report is available in its catalogue. ,, Pi...ve ,, http://www.reportlinker.com/p0164373/P...tml#utm_source=prnewswire&utm_medium=pr&ut...rs are treated as an integral part of any research...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 R...ch report is available in its catalogue. ,, Me... ,, http://www.reportlinker.com/p0164242/Medi...ml#utm_source=prnewswire&utm_medium=pr&utm...hesives and sealants is gaining preeminence in med...
(Date:11/20/2009)..., , PLYMOUTH MEETING, Pa., Nov. 20 /PRNew...York Times article that questions why currently a... some cancers are being ignored, ECRI Institute, a...a roadmap to the evidence on Finasteride for Prev..., The November 13, 2009, New York Times articl...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3ESA helps make summer in the city more bearable 9714 1ESA helps make summer in the city more bearable 9714 2ESA helps make summer in the city more bearable 9714 3ESA helps make summer in the city more bearable 9714 4U Iowa improves delivery of cancer fighting molecules 9711 1U Iowa improves delivery of cancer fighting molecules 9711 2KoolDocs com Increases Online Presence through Social Networking Premium Online Medical Consultation Service Now on Facebook Twitter and LinkedIn 55518 1KoolDocs com Increases Online Presence through Social Networking Premium Online Medical Consultation Service Now on Facebook Twitter and LinkedIn 55518 2
... Activities of Daily Living Data from Pivotal Tria...eurology 60th Annual Meeting -, SAN FRANCISCO and...N ) today announced that Alzheimer,s patients,taki...nificant improvement,in their ability to perform d...ebo. This improvement allowed caregivers to save a...
...AN DIEGO and SUNNYVALE, Calif., April 15 ,Pharmacy...inical data from,four presentations at the Annual ...earch (AACR) being held this week in San Diego, CA... company,s novel, histone deacetylase,(HDAC) inhib...., "These presentations demonstrate the breadth o...
Other Medicine Technology:Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 2Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 3Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 4Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance 5Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors 2Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors 3Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors 4
Prechopper curved
Medina Irrigating Nucleus Chopper
Rosen Irrigating Nucleus Chopper
Agarwal Irrigating Nucleus Chopper
Medicine Products: